SFX by Ex Libris Inc.

Title:	Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Kawatkar, Sameer yr:2020

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Mandal, M. "The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck." Oral oncology 42.4 (2006): 430-439.
description	2.	Galkin, Anna V. "Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK." Proceedings of the National Academy of Sciences of the United States of America 104.1 (2007): 270-5.
description	3.	Cohen, Michael S. "Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors." Science 308.5726 (2005): 1318-1321.
description	4.	ZHU, G. "Isoquinoline-pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activity." Bioorganic & medicinal chemistry letters 16.12 (2006): 3150-3155.
description	5.	Shokat, Qi-Wen E. "A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma." Cancer cell 9.5 (2006): 341-9.
description	6.	Harrowven, D. C. "The first total synthesis of toddaquinoline, an alkaloid from Toddalia asiatica." Tetrahedron 57.20 (2001): 4447-4454.
description	7.	Heymach, John V. "Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of Non-Small Cell Lung Cancer." Clinical cancer research 12.14 (2006): 4441-9.
description	8.	KNIGHT, Zachary A. "A pharmacological map of the PI3-K family defines a role for p110Î± in insulin signaling." Cell 125.4 (2006): 733-747.
description	9.	Li, Q. "Synthesis and structure-activity relationship of 3,4 '-bispyridinylethylenes: Discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer." Bioorganic & medicinal chemistry letters 16.7 (2006): 2000-2007.
description	10.	Li, Q. "Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation." Bioorganic & medicinal chemistry letters 16.6 (2006): 1679-1685.
description	11.	Liu, K. "Pokemon silencing leads to bim-mediated anoikis of human hepatoma cell QGY7703." International journal of molecular sciences 13.5 (2012): 5818-5831.
description	12.	Sato, T. "CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299." Cancer research 65.15 (2005): 6950-6.
description	13.	Christensen, James G G. "Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma." Molecular cancer therapeutics 6.12 (2008): 3314-22.
description	14.	Okram, B. "A general strategy for creating "inactive-conformation" abl inhibitors." Chemistry & biology 13.7 (2006): 779-86.
description	15.	Lim, Mi Jung J. "Nucleophosmin and human cancer." Cancer detection and prevention 30.6 (2006): 481-90.
description	16.	Chen, Emily I I. "Adaptation of energy metabolism in breast cancer brain metastases." Cancer research 67.4 (2007): 1472-86.
description	17.	DeFeo-Jones, D. "Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members." Molecular cancer therapeutics 4.2 (2005): 271-279.
description	18.	Krasovskiy, A. "Mixed Mg/Li amides of the type R2NMgClâ LiCl as highly efficient bases for the regioselective generation of functionalized aryl and heteroaryl magnesium compounds." Angewandte Chemie (International ed.) 45.18 (2006): 2958-2961.
description	19.	Narisawa-Saito, Mako, M. "Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins." Cancer Science 98.10 (2007): 1505-1511.
description	20.	Douville, E. "EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2." Oncogene 15.4 (1997): 373-83.